These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8299398)

  • 1. Clinical and prognostic features of advanced ovarian carcinoma.
    Lund B
    Dan Med Bull; 1993 Nov; 40(5):537-45. PubMed ID: 8299398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epithelial ovarian cancer: a challenge in gynecologic oncology].
    Dauplat J; Piccart M
    Pathol Biol (Paris); 1992 Nov; 39(9):823-4. PubMed ID: 1538891
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
    Lee YY; Choi CH; Do IG; Song SY; Lee W; Park HS; Song TJ; Kim MK; Kim TJ; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Aug; 122(2):361-5. PubMed ID: 21570711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy in advanced forms of carcinoma of the ovary].
    Calciati A; Clerico M; Donadio M; Giaccone G
    Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY; Huang H; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasonics and computer tomography--controlling methods in treatment with Platidiam].
    Novotná J; Freitag P; Kobilková J; Cepický P; Laurová L
    Cesk Gynekol; 1984 Aug; 49(7):499-501. PubMed ID: 6386194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic factors in ovarian epithelial cancer].
    Nishida T
    Gan To Kagaku Ryoho; 1996 May; 23(6):805-9. PubMed ID: 8645035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a standard therapy in advanced ovarian carcinoma?].
    Köchli OR
    Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
    Hess LM; Barakat R; Tian C; Ozols RF; Alberts DS
    Gynecol Oncol; 2007 Nov; 107(2):260-5. PubMed ID: 17675142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High dose chemotherapy: an overview in ovarian carcinoma].
    Möbus VJ
    Zentralbl Gynakol; 1996; 118(10):573-4. PubMed ID: 8999713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined chemo-hormone therapy in advanced ovarian cancer. Results of the 2d Austrian ovarian cancer study].
    Sevelda P
    Gynakol Rundsch; 1990; 30 Suppl 1():57-61. PubMed ID: 2150399
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J; Du Bois A
    MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
    Vergote I; Amant F
    Gynecol Oncol; 2006 Sep; 102(3):415-7. PubMed ID: 16979430
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy for ovarian cancer.
    Cvitkovic E; Misset JL
    N Engl J Med; 1996 May; 334(19):1269; author reply 1270. PubMed ID: 8606730
    [No Abstract]   [Full Text] [Related]  

  • 19. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
    Munkarah A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
    [No Abstract]   [Full Text] [Related]  

  • 20. The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.
    Gadducci A; Cosio S; Fanucchi A; Negri S; Cristofani R; Genazzani AR
    Gynecol Oncol; 2004 Apr; 93(1):131-6. PubMed ID: 15047226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.